Skip to main content
. 2017 Nov 17;131(3):301–310. doi: 10.1182/blood-2017-07-795047

Table 4.

Second primary malignancies

SPM Rd continuous (n = 532) Rd18 (n = 540) MPT (n = 541)
Invasive, n (%) 36 (7) 38 (7) 46 (9)
 Hematologic 4 (1) 2 (<1) 14 (3)
  AML 1 (<1) 1 (<1) 5 (1)
  MDS 2 (<1) 1 (<1) 5 (1)
  MDS to AML 0 0 4 (1)
  B-cell leukemia 1 (<1) 0 0
 Solid tumor 32 (6) 37 (7) 32 (6)

AML, acute myeloid leukemia; MDS, myelodysplastic syndromes.